The Carlyle Group Acquires Majority Stake in TriNetX

September 21, 2020

The Carlyle Group has made a strategic growth investment to acquire a majority stake in TriNetX, a global health research network that provides real-world clinical and claims data and analytics. Carlyle's investment will accelerate TriNetX's development of clinical research capabilities, support global expansion, and fund both organic and inorganic growth opportunities.

Buyers
The Carlyle Group
Targets
TriNetX
Location
Massachusetts, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.